José Berciano | Neuroscience | Best Researcher Award

Prof. Dr. José Berciano | Neuroscience | Best Researcher Award

Honorary Emeritus Professor, University of Cantabria, Spain

Prof. Dr. José Berciano is a distinguished neurologist and researcher at the University of Cantabria, Spain, with a career spanning over four decades in clinical neurology, research and teaching. He obtained his Degree in Medicine and Surgery from the University of Zaragoza (1962–1968) and completed his postgraduate training in Neurology at Clínica Puerta de Hierro, Madrid (1969–1973), under the mentorship of Dr. Alberto Gimeno Álava. He earned his doctoral degree in 1978 from the University of the Basque Country with a thesis on “New Contributions to the Clinical and Pathological Understanding of Olivo-Ponto-Cerebellar Atrophy,” which introduced a classification system distinguishing hereditary and sporadic forms. Prof. Dr. José Berciano’s professional experience includes serving as Head of the Neurology Department at Marqués de Valdecilla University Hospital (1974–2015), where he established the Peripheral Nerve Histopathology Laboratory and the Neurogenetics Laboratory, fostering advanced genetic analyses, immunocytochemistry and confocal microscopy for the study of neurodegenerative and hereditary disorders. His research interests encompass hereditary ataxias and paraplegias, Charcot–Marie–Tooth disease, Guillain–Barré syndrome, stroke, Chiari malformation, Sneddon syndrome, multiple sclerosis and ALS. Prof. Dr. José Berciano has authored 516 publications with 15,952 citations and an h-index of 59, supervised 20 doctoral theses, contributed to 70 books or book chapters and led 17 competitive research projects, often collaborating internationally with research teams across Europe and the USA. His research skills include neurogenetics, clinical neurophysiology, neuropathology, epidemiology and translational neuroscience. He has received numerous awards and honors, including the Holmes’ Prize of Ataxia, Galien Prize for Best Research Laboratory, Scientific Awards from the Spanish Society of Neurology and Honorary Membership of SEN. Prof. Dr. José Berciano is highly deserving of recognition for his seminal contributions to neurology, leadership in research and education, mentorship of future neurologists and ongoing potential to advance high-impact, internationally collaborative neuroscience studies.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | Loop | AD Scientific Index | Scholargps

Featured Publications

1. Schmitz-Hubsch, T., Du Montcel, S. T., Baliko, L., Berciano, J., Boesch, S., et al. (2006). Scale for the assessment and rating of ataxia: Development of a new clinical scale. Neurology, 66(11), 1717–1720.

2. Healy, D. G., Falchi, M., O’Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., et al. (2008). Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: A case-control study. The Lancet Neurology, 7(7), 583–590.

3. Fanciulli, A., & Wenning, G. K. (2015). Multiple-system atrophy. New England Journal of Medicine, 372(3), 249–263.

4. Querol, L., Nogales-Gadea, G., Rojas-Garcia, R., Diaz-Manera, J., Pardo, J., et al. (2014). Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology, 82(10), 879–886.

5. Pascual, J., Iglesias, F., Oterino, A., Vazquez-Barquero, A., & Berciano, J. (1996). Cough, exertional, and sexual headaches: An analysis of 72 benign and symptomatic cases. Neurology, 46(6), 1520–1524.

 

Pan Wang | Neuroscience | Best Researcher Award

Dr. Pan Wang | Neuroscience | Best Researcher Award

Postdoctoral Researcher at Affiliated First Hospital of Zhejiang University School of Medicine, China.

Dr. Pan Wang is a postdoctoral researcher at the Department of Pathology, Zhejiang University School of Medicine. With a background in human anatomy, embryology, and pathology, Dr. Wang’s research focuses on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s disease. His work explores molecular pathways, extracellular vesicles, and neurovascular mechanisms in disease pathogenesis and diagnosis.

Publication Profile

Scopus

Educational Details

  • Ph.D. in Human Anatomy and Embryology – China Medical University, China (2016-2020)

  • M.S. in Human Anatomy and Embryology – Jinzhou Medical University, China (2009-2012)

  • B.S. in Clinical Medicine – Jinzhou Medical University, China (2004-2009)

Professional Experience

Dr. Wang has extensive experience in neuropathology research. Since 2021, he has been a postdoctoral researcher at Zhejiang University, investigating spatial transcriptomics and disease biomarkers in Alzheimer’s and Parkinson’s disease. Before that, he worked as an Assistant Researcher in the Department of Neurobiology at Jinzhou Medical University (2012–2016), where he contributed to studies on synaptic dysfunction, neuroinflammation, and vascular pathology in neurodegenerative conditions.

Research Interest

  • Molecular mechanisms of Alzheimer’s & Parkinson’s disease

  • Neurovascular interactions and blood-brain barrier dysfunction

  • Role of extracellular vesicles in neurodegeneration

  • Spatial transcriptomics and precision diagnostics in neuropathology

Author Metrics

As of April 2025, Dr. Pan Wang has authored over 8 publications, with a total citation count exceeding 3,200 and an h-index of 25. These metrics reflect the impact and recognition of his research contributions in the scientific community.

Top Noted Publication

  • Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas

    • Journal: Neuron (2025)

    • DOI: 10.1016/j.neuron.2025.03.002

    • Summary: Investigates molecular mechanisms in the hippocampus using spatial transcriptomics to advance Alzheimer’s disease diagnostics.

  • α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis

    • Journal: Translational Neurodegeneration (2023)

    • DOI: 10.1186/s40035-023-00372-y

    • Summary: Identifies the role of astrocytic extracellular vesicles in the spread of α-synuclein and their potential as diagnostic markers in Parkinson’s disease.

  • Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease

    • Journal: Neural Regeneration Research (2021)

    • DOI: 10.4103/1673-5374.295349

    • Summary: Explores melatonin’s neuroprotective effects on microvascular dysfunction in Alzheimer’s disease.

  • Regulatory role of melatonin in Notch1 signaling pathway in cerebral cortex of Aβ(1-42)-induced Alzheimer’s disease rat model

    • Journal: Molecular Biology Reports (2023)

    • DOI: 10.1007/s11033-022-08213-3

    • Summary: Examines melatonin’s modulation of Notch1 signaling in Alzheimer’s pathology.

  • Effects of the genetic knockout of the β-1,3-galactosyltransferase 2 on spatial learning and neurons in the adult mouse hippocampus and somatosensory cortex

    • Journal: Neuroreport (2023)

    • DOI: 10.1097/wnr.0000000000001857

    • Summary: Investigates the impact of β-1,3-galactosyltransferase 2 knockout on cognitive functions and neurodevelopment.

  • Protective effect of melatonin on soluble Aβ1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus

    • Journal: Alzheimer’s Research & Therapy (2016)

    • DOI: 10.1186/s13195-016-0206-x

    • Summary: Demonstrates melatonin’s protective role against Aβ1-42-induced neurotoxicity.

  • Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson’s disease

    • Journal: Glia (2022)

    • DOI: 10.1002/glia.24109

    • Summary: Identifies VEGFA as a critical factor in blood-brain barrier dysfunction in Parkinson’s disease.

  • Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson’s Disease

    • Journal: Movement Disorders (2024)

    • DOI: [Pending]

    • Summary: Explores the gut-brain axis in Parkinson’s disease, focusing on erythrocytic α-synuclein interactions with the microbiome.

Conclusion

Dr. Pan Wang is a highly qualified candidate for the Best Researcher Award, given his impactful contributions to neuroscience, strong publication record, and high citation count. His expertise in neurodegenerative diseases and innovative research techniques positions him as a leading figure in his field.

To further strengthen his candidacy, expanding international collaborations, securing research funding, and taking on leadership roles would elevate his profile for top-tier research awards.